Gene expression in hair follicle dermal papilla cells after treatment with stanozolol

Biomarker Insights

Volumn 2009, Issue 4, 2009, Pages 1-8

  Reiter, Martina ^a   Pfaffl, M W ^a   Schonfelder M ^a   Meyer, H H D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anabolic agents; Gene expression; Hair follicle dermal papilla cells; MRNA; qRT PCR

Indexed keywords

ANDROGEN RECEPTOR; BETA ACTIN; BIOLOGICAL MARKER; CASPASE 8; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FAS ANTIGEN; FAS LIGAND; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH HORMONE RECEPTOR; KERATINOCYTE GROWTH FACTOR; PROTEIN BCL 2; RNA; SOMATOMEDIN RECEPTOR; STANOZOLOL; STEROID 5ALPHA REDUCTASE 1; STEROID 5ALPHA REDUCTASE 2; STEROID RECEPTOR; UBIQUITIN; ANABOLIC AGENT; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; SOMATOMEDIN;

ADULT; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HUMAN CELL; MALE; MEDICAL LITERATURE; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; CONCENTRATION RESPONSE; DOPING; DRUG MECHANISM; FEASIBILITY STUDY; GENE TARGETING; REAL TIME POLYMERASE CHAIN REACTION;

EID: 59849111322     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/bmi.s1173     Document Type: Article

References (28)

1. Anielski, P., Thieme, D., Schlupp, A., Grosse, J., Ellendorf, F. and Mueller, R.K. 2005. Detection of testosterone, nandrolone and precursors in horse hair. Anal. Bioanal. Chem., 383(6):903-8.
2. Ayotte, C. 2006. Significance of 19-norandrostenedione in athletes'urine samples. Br. J. Sports Med., 40:25-9.
3. Black, M.A., Lefebvre, F.A., Pope, L., Lefebvre, Y.A. and Walker, P. 1992. Thyroid hormone and androgen regulation of nerve growth factor gene expression in the mouse submandibular gland. Mol. Cell Endocrinol., 84(1-2):145-54.
4. Catlin, D.H., Hatton, C.K. and Starcevic, S.H. 1997. Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes'urine. Clinical Chemistry, 43;7:1280-8.
5. Clasing, D. and Müller, R.K. Dopingkontrolle 2006. 4, überarbeitete Auflage. Bundesinstitut für Sportwissenschaften, 2006.
6. Darbre, P., Yated, J., Curtis, S. and King, RJB. 1983. Effect of estradiol on human breast cancer cells in culture. Cancer Res., 43:349-54.
7. Duntas, L.H. and Parisis, C. 2003. Doping: a challenge to the endocrinologist. A reappraisal in view of the Olympic Games of 2004. Hormones, 2(1):35-42.
8. Fleige, S. and Pfaffl, M.W. 2006. RNA integrity and the effect on the realtime qRT-PCR. performance. Mol. A. Med., 27:126-39.
9. Gambelunghe, C., Sommavilla, M., Ferranti, C., Rossi, R., Aroni, K., Manes, N. and Bacci, M. 2007. Analysis of anabolic steroids in hair by GC/MS/MS. Biomed Chromatogr, Feb(12):
10. Gleixner, A., Sauerwein, H. and Meyer, HHD. 1996. Detection of anabolic 2-adrenoreceptor agonist clenbuterol in human sclap hair by HPLC/EIA. Clinical Chem., 42(11).
11. Griggs, R.C., Kingston, W., Jozefowicz, R.F., Herr, B.E. and Forbes, G. 1989. Halliday D. Effect of testosterone on muscle and muscle protein synthesis. J. Appl. Physiol., 66(1):498-503.
12. Hartgens, F. and Kuipers, H. 2004. Effects of androgenic-anabolic steroids in athletes. Sports Med., 34(8):513-54.
13. Hickson, R.C., Czerwinski, S.M., Falduto, M.T. and Young, A.P. 1990. Glucocorticoid antagonism by exercise and androgenic-anabolic steroids. Med. Sci. Sports Exerc., 22(3):331-40.
14. Kuhn, C.M. 2002. Anabolic Steroids. Recent Prog. Horm. Res., 57:411-34.
15. Livak, K.J. and Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR. and the 2(-Delta Delta C(T)) Method. Methods, 25:402-8.
16. Melchert, R.B., Herron, T.J. and Welder, A.A. 1992. The effect of anabolic-androgenic steroids on primary myocardial cell cultures. Med. Sci. Sports Exerc., 24(2):206-12.
17. Mitusi, S., Ohuchi, A., Hotta, M., Tsuboi, R. and Ogawa, H. 1997. Genes for a range of growth factors and cyclin-dependent kinase inhibitors are expressed by isolated human hair follicles. Br. J. Dermatol., 137:693-8.
18. Ota, Y., Sioth, Y., Suzuki, S., Ozawa, K., Kawano, M. and Imamura, T. 2002. Fibroblast growth factor 5 inhibits hair growth by blocking dermal papilla cell activation. Biochem. Biophys. Res. Commun., 11;(290(1)):169-76.
19. Philpott, M.P., Green, M.R. and Kealey, T. 1994. Human hair growth in vitro. J. Dermatol. Sci., 7(Suppl):S55-72.Review.
20. Reiter, M., Walf, V.M., Christians, A., Pfaffl, M.W. and Meyer, HHD. 2006. Modification of mRNA expression after treatment with anabolic agents and its usefulness for gene expression-biomarkers. Anal. Chim. Acta., 586(1-2):73-81.
21. Schänzer, W. 1996. Metabolism of anabolic androgenic steroids. Clinical Chemistry, 42:7.
22. Schlake, T. 2005. FGF signals specifically regulate the structure of hair shaft medulla via IGF-binding protein 5. Development, 132:2981-90.
23. Schroeder, A. and Mueller, O. 2006. Stocker S et al.The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol. Biol., 31(7):3.
24. Schönfleder, M. and Einspanier, R. 2003. Expression of hyaluronan synthases and corresponding hyaluronan receptors is differentially regulated during oocyte maturation in cattle. Biol. Repord, 69(1):269-77.
25. Stenn, K.S. and Paus, R. 2001. Controls of hair follicle cycling. Pharm. Rev., 81(1):
26. Tang, L., Bernardo, O., Bolduc, C., Lui, H., Madani, S. and Shapiro, J. 2003. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia. J. Am. Acad. Dermatol., 49(2):229-33.
27. Thieme, D., Grosse, J., Sachs, H. and Mueller, R.K. 2000. Analytical strategy for detecting doping agents in hair. Forensic Science International, 107:335-45.
28. Weger, N. and Schlake, T. 2005. IGF-1 signalling controls the hair growth cycle in the differentiation of hair shafts. J. Invest. Dermatol., 125:873-82.